Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Caroline J. Chapman"'
Autor:
Farah Khasawneh, Timothy Osborne, Paul Danaher, Daniel Barnes, Caroline J. Chapman, James A. Stephenson, Baljit Singh
Publikováno v:
Colorectal Disease. 25:640-646
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3403981bd1de68b8a96ce95e64994743
https://doi.org/10.1111/codi.16445
https://doi.org/10.1111/codi.16445
Autor:
Inas M. Alhudiri, Christopher C. Nolan, Ian O. Ellis, Emad A. Rakha, Adam Elzagheid, Andrew R. Green, Caroline J. Chapman
Publikováno v:
Cancer Research. 82:5405-5405
Purpose: Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. The expression of Cathepsin D is regulated by steroid hormones including oestrogen and growth fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bafca616dc53da41e83aabb90dc2dfa5
https://doi.org/10.1158/1538-7445.am2022-5405
https://doi.org/10.1158/1538-7445.am2022-5405
Autor:
Jaren Allen, Richard F A Logan, Natasha Djedovic, Joanne R Morling, Simon Oliver, David J. Humes, A Banerjea, Caroline J Chapman, Abby Ford, Katie Hardy
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 59:721-728
Objectives Currently, NICE recommends the use of faecal immunochemical test (FIT) at faecal haemoglobin concentrations (f-Hb) of 10 μg Hb/g faeces to stratify for colorectal cancer (CRC) risk in symptomatic populations. This f-Hb cut-off is advised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c759a36066caf98566cd4fa9286fd6
https://doi.org/10.1515/cclm-2020-1170
https://doi.org/10.1515/cclm-2020-1170
Autor:
Joanne R Morling, James Bailey, David J. Humes, A Banerjea, Caroline J. Chapman, Jaspreet K. Seehra
Publikováno v:
The British Journal of Surgery
Aims Faecal Immunochemical Tests (FIT) are increasingly used for stratification of colorectal cancer risk in symptomatic patients. FIT is not currently recommended for use in patients with rectal bleeding, but recent studies have reported its safe us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57304c4a79b0966deed59988fb69f33a
https://doi.org/10.1093/bjs/znab311.043
https://doi.org/10.1093/bjs/znab311.043
Autor:
Catrin H Middleton, William Irving, John F R Robertson, Andrea Murray, Celine B Parsy-Kowalska, Isabel K Macdonald, Jane McElveen, Jared Allen, Graham F Healey, Brian J Thomson, Stephen J Ryder, Stefan Holdenrieder, Caroline J Chapman
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103867 (2014)
BACKGROUND: Individuals with liver disease, and especially those with Hepatitis B or C, are at an increased risk of developing hepatocellular carcinoma (HCC) which is the third most common cause of cancer-related death worldwide. Inadequate screening
Externí odkaz:
https://doaj.org/article/4dca7442513c4446a6c64c6c158599b5
Autor:
Caroline Addison, Stephen Smith, Christian von Wagner, Caroline J. Chapman, Stephen P Halloran, Allan Hackshaw, Rosalind Raine, Paul Greliak, Amanda J. Cross, Stephen W. Duffy, Natasha Djedovic, Jonathan P. Myles, Sally C Benton
Objectives To evaluate the effect of general practitioner endorsement accompanying the screening kit rather than with the invitation letter on participation in the NHS Bowel Cancer Screening Programme and on the socioeconomic gradient in participatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b309c3d0de1211d97137465020d96180
http://hdl.handle.net/10044/1/87400
http://hdl.handle.net/10044/1/87400
Publikováno v:
Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd7463acd988d2304c8db3b1e9020e70
https://doi.org/10.1136/gutjnl-2020-bsgcampus.368
https://doi.org/10.1136/gutjnl-2020-bsgcampus.368
Autor:
A Banerjea, James Bailey, Caroline J. Chapman, Jill Weller, J. A. Simpson, David J. Humes, Joanne R Morling
Publikováno v:
Posters.
Introduction National guidelines on the investigation of cancer recommends patients with a 3% risk or greater are investigated on an urgent cancer pathway. A review of outcomes two years after the incorporation of FIT into a 2-week-wait (2WW) pathway
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac5b4117eabd99e387812dcfce19ce91
https://doi.org/10.1136/gutjnl-2020-bsgcampus.364
https://doi.org/10.1136/gutjnl-2020-bsgcampus.364
Autor:
Celine B. Parsy-Kowalska, Jane McElveen, Christopher Welberry, Isabel Macdonald, Graham F. Healey, Jared Allen, William L. Irving, Caroline J. Chapman, Andrea Murray
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232247 (2020)
PLoS ONE
PLoS ONE
BackgroundHepatocellular carcinoma (HCC) continues to be a leading challenge in modern oncology. Early detection via blood-based screening tests has the potential to cause a stage-shift at diagnosis and improve clinical outcomes. Tumor associated aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5355a3af8881d98d40c692f5ce3f6f61
https://doaj.org/article/96fb10f3039a4345a318369e9aa4e016
https://doaj.org/article/96fb10f3039a4345a318369e9aa4e016
Autor:
Isabel K Macdonald, Jared Allen, Andrea Murray, Celine B Parsy-Kowalska, Graham F Healey, Caroline J Chapman, Herbert F Sewell, John F R Robertson
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40759 (2012)
An assay employing a panel of tumor-associated antigens has been validated and is available commercially (EarlyCDT®-Lung) to aid the early detection of lung cancer by measurement of serum autoantibodies. The high throughput (HTP) strategy described
Externí odkaz:
https://doaj.org/article/30b6bdc9b68c4fcf9e3b714380df206a